References
- Acheson R. M., Booth D. A., Brettle R., Harris A. M. The synthesis of some acylglycine and related oxazolonesl. Journal of the Chemical Society 1960; 3457–3461
- Fessenden R. J., Ahlfors C. The metabolic fate of some silicon-containing carbamates. Journal of Medicinal Chemistry 1967; 10: 810–812
- Fessenden R. J., Hartman R. A. The metabolic fate of phenyltrimethysilane and phenyldimethylsilane. Journal of Medicinal Chemistry 1970; 13: 52–54
- Masumto H., Shigeru O., Masaaki H. Application of chemical cytochrome P-450 model systems to studies on drug metabolism. Drug Metabolism and Disposition 1991; 19: 768–780
- Morris G A., Freeman R. Enhancement of nuclear magnetic resonance signals by polarization transfer. Journal of the American Chemical Society 1979; 101: 760–762
- Orwig B. A., Fu E. W., Shapiro M. J., Dain J. G., Barcza S. Isolation and identification of the major metabolite of SDZ 58–035, a novel organosilicon hypocholesteremic agent. Pharmaceutical Research 1991; 8: S-240
- Steward O. W., Dziedzic J. E., Johnson J. S. Carboxysilanes and -germanes. II. Synthesis and spectra; properties of triorganosilane- and triorganogermanecarboxylic acid. Journal of Organic Chemistry 1971; 36: 3475–3480
- TsE F. L. S., Jaffe J. Disposition of a silicon-containing amide, an inhibitor of acyl-CoA:cholesterol acyltransferase in dog and rat. Biopharmaceutics and Drug Disposition 1987; 8: 437–448
- Tse F. L. S., Jaffe J., Dain J. G. Pharmacokinetics of compound 58–112, a potential skeletal muscle relaxant, in man. Journal of Clinical Pharmacology 1984; 24: 45–57